Thymidylate synthase (TS) is a major target in the chemotherapy of colorectal cancer and some other neoplasms. The emergence of resistance to the treatment is often related to the increased levels of TS in cancer cells, which have been linked to the elimination of TS binding to its own mRNA upon drug binding, a feedback regulatory mechanism, and/or to the increased stability to intracellular degradation of TS⅐drug complexes (versus unliganded TS). The active site loop of human TS (hTS) has a unique conformation resulted from a rotation by 180°relative to its orientation in bacterial TSs. In this conformation, the enzyme must be inactive, because the catalytic cysteine is no longer positioned in the ligandbinding pocket. The ordered solvent structure obtained from high resolution crystallographic data (2.0 Å) suggests that the inactive loop conformation promotes mRNA binding and intracellular degradation of the enzyme. This hypothesis is supported by fluorescence studies, which indicate that in solution both active and inactive forms of hTS are present. The binding of phosphate ion shifts the equilibrium toward the inactive conformation; subsequent dUMP binding reverses the equilibrium toward the active form. Thus, TS inhibition via stabilization of the inactive conformation should lead to less resistance than is observed with presently used drugs, which are analogs of its substrates, dUMP and CH 2 H 4 folate, and bind in the active site, promoting the active conformation. The presence of an extension at the N terminus of native hTS has no significant effect on kinetic properties or crystal structure.
Thymidylate synthase (TS) 1 catalyzes the reductive methylation of 2Ј-deoxyuridine 5Ј-monophosphate (dUMP) to thymidine 5Ј-monophosphate (dTMP), using the co-substrate, 5,10-methylenetetrahydrofolate (CH 2 H 4 folate) as a 1-carbon donor and reductant. The physical structures of bacterial TSs have been relatively well defined, and crystallographic data, in concert with data derived from kinetic, spectroscopic, and sitedirected mutagenesis studies, have led to a detailed understanding of the catalytic mechanism of these enzymes (1) . In contrast, relatively few investigations of mammalian TS structure and catalysis have been conducted. The three-dimensional structure of the native human TS (hTS) has been reported previously (2) . The data showed a surprising feature not observed in TSs from other sources: loop 181-197 containing the catalytic cysteine, Cys-195, was in an inactive conformation, rotated ϳ180°with respect to its orientation in bacterial TSs, with the sulfhydryl of Cys-195 over 10 Å from the location of sulfhydryls of corresponding cysteine residues in bacterial enzymes. Subsequent determination of the structure of a ternary inhibitory complex between closely related ratTS (rTS) and dUMP and Tomudex (3) has shown that the ligands bind to the enzyme in the active conformation. Recently, it was found that also in the hTS⅐dUMP⅐Tomudex complex hTS is in the active conformation (4) . The inactive conformation has not been observed in TSs other than human. TS has been a primary target for chemotherapy aimed at cancers of the gastrointestinal tract and head and neck (5) despite moderate response in 30 -40% of patients. A major problem affecting TS-directed treatments is that tumor cells often react to an exposure to TS inhibitors by raising levels of intracellular TS activity about 2-to 4-fold, which may lead to resistance. The levels of TS mRNA do not change significantly; the increase is predominantly at the protein level. Two effects have been found that can explain the observed increased TS levels. TS was observed to bind to its own mRNA, which is proposed to act as a feedback inhibition mechanism regulating TS levels (6) . When TS is bound by its physiological substrates, dUMP and/or CH 2 H 4 folate, or inhibitors, FdUMP or antifolates, it is unable to interact with its own mRNA. The endresult of this disruption in RNA binding is relief of translational repression with resultant synthesis of new TS. Other * This work was supported by National Institutes of Health Grant CA76560 and the South Carolina Cancer Center. Some instrumentation used in this research was purchased with National Science Foundation Grant BIR9419866 and United States Department of Energy Grant DE-FG-95TE00058. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, under contract W-31-109-ENG-38. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The researchers (7), using different cell lines, did not observe changes in the extent of ribosome binding to TS mRNA in the presence of TS inhibitors but have shown in an elegant way that ligand-mediated induction of TS occurs by lowering protein turnover. The primary structure of hTS differs from that of bacterial TSs in three regions: the N terminus of hTS is extended (by 29 residues with respect to the most studied Escherichia coli TS, ecTS) and two insertions of 12 and 8 residues are present at positions 117 and 146, respectively, in the human protein (1) . Recent studies of hTS isolated from bacteria as a recombinant protein and TS isolated from human cells suggested that catalytic and some RNA binding activities of these enzymes are dependent upon the N terminus (8) . The sole difference between the proteins was the presence of a blocked N terminus, probably acetylation, in the enzyme isolated from human cells. In addition, a recombinant hTS in which the N terminus was blocked with a polyhistidine peptide exhibited catalytic and RNA binding activity similar to that of the native, blocked protein (8) . These data suggested that the N terminus influences enzyme function. Interestingly, the recombinant human enzyme that was utilized as the source for the originally studied crystals was heterogeneous; ϳ80% of the protein was a fusion protein containing an additional 13 amino acids at the N terminus (see Fig. 1 ) that are not present in human TSs (2) . The original structure determination of the native hTS was at medium (3.0 Å) resolution, and the solvent structure could not have been analyzed. We report here the first determination of high resolution, 2.0 Å, structures of recombinant unblocked hTS and NTE-hTS, both with well-defined solvent structures, and kinetic and ligand binding studies for NTE-hTS. Analysis of the solvent structure suggested that phosphate ions stabilize the inactive conformation. We have conducted fluorescence studies that support this hypothesis.
EXPERIMENTAL PROCEDURES
Materials-Nucleotides, salts, isopropyl-␤-D-thiogalactopyranoside, 2-mercaptoethanol (2-ME), phenylmethylsulfonyl fluoride, ethanediol, polyethylene glycols (PEGs), and folic acid were obtained from Sigma Chemical Co. (St. Louis, MO). Ultra-pure ammonium sulfate was from ICN Biomedicals, Inc. (Aurora, OH). Restriction enzymes and T4 DNA ligase were from New England BioLabs (Beverly, MA). (6S)-5,6,7,8-Tetrahydrofolic acid (H 4 folate) was prepared from folic acid and converted to (6R)-CH 2 H 4 folate as described previously (9) .
Expression and Purification of Human Thymidylate Synthase-Recombinant hTS was expressed and purified as described previously (10) . The plasmid pCD1 used to express N-terminally extended hTS (NTEhTS) with an additional 42 amino acids at the N terminus ( Fig. 1) was created by subcloning the human thyA gene from the plasmid pDHTS-1 (11) into the expression vector pProEX-1 (Life Technologies, Inc., Gaithersburg, MD). The bacterial strain X2913, which has a deletion of the Escherichia coli thyA gene, was transformed with plasmid pCD1 using the CaCl 2 /heat shock method (12) . Transformants were grown in Luria Bertani (LB) medium containing 100 g/ml ampicillin. At A 600 of 1.0, isopropyl ␤-D-thiogalactopyranoside was added to a final concentration of 0.6 mM. The culture was incubated for 4 h, cells were harvested by centrifugation at 1000 ϫ g at 4°C, and frozen at Ϫ70°C. Cell pellets (2-3 g) were thawed on ice and suspended in buffer X (20 mM Tris, 100 mM KCl, 20 mM imidazole, and 14 mM 2-ME at pH 8.5 and 4°C) containing 0.1 mM phenylmethylsulfonyl fluoride. Cells were lysed at 4°C by sonication using a Branson Sonifier 450 (Branson Ultrasonics, Danbury, CT). Cell debris was removed by centrifugation at 18,000 ϫ g at 4°C for 30 min. NTE-hTS was purified from the cell-free extract at 4°C using a nickel-nitrilotriacetic acid column (Qiagen, Chatsworth, CA). The cell extract was loaded onto the column and washed with buffer X. The column was then washed with buffer Y (20 mM Tris, 1 M KCl, and 14 mM 2-ME, pH 8.5) and NTE-hTS was eluted with buffer Z (20 mM Tris, 100 mM KCl, 100 mM imidazole, and 14 mM 2-ME, pH 8.5). Fractions containing NTE-hTS were pooled and dialyzed overnight against buffer A (10). Purified NTE-hTS was analyzed by 12% SDSpolyacrylamide gel electrophoresis for purity and stored in buffer A containing 15% glycerol at Ϫ20°C.
Steady-state Kinetic Measurements-Enzyme activity was measured spectrophotometrically by monitoring the absorbance change accompanying the conversion of CH 2 H 4 folate to H 2 folate (13) using either a Shimadzu UV 1601 spectrophotometer equipped with a TCC 240A temperature-controlled cell holder or a Shimadzu UV 2101 PC spectrophotometer (Shimadzu Corp., Columbia, MD). Measurements were carried out at 25°C and pH 7.4 in Morrison buffer (14) . One unit of enzyme activity is defined as the amount of enzyme required to synthesize 1 mol of dTMP per minute. Enzyme concentration was determined by measurement of absorbance at 280 nm, as described previously (15) .
Transient-state Kinetic Measurements-Kinetic data describing the binding of ligands with hTS were obtained using a stopped-flow fluorimeter/spectrometer (Hi-Tech SX.18MV, Applied Photophysics, UK) as described previously (10, 16 Crystallization of Human Thymidylate Synthase-Crystals of unblocked hTS and NTE-hTS were grown by the vapor diffusion method in the hanging-drop setup at conditions similar to those reported previously (2). Typically, 5 l of enzyme solution (18 mg/ml) containing 1 mM EDTA, 10 mM 2-ME, 0.1-1 M potassium chloride, 100 mM imidazole (NTE-hTS), 50 mM Tris-HCl (pH 7.5-8.5) was mixed with an equal volume of precipitant solution containing 38 -50% saturated ammonium sulfate, 40 mM potassium phosphate, 20 mM 2-ME, and 100 mM Tris-HCl (pH 7.8), and allowed to equilibrate with 0.6 ml of precipitant solution present in the well. The culture plates were stored undisturbed at room temperature, and crystals appeared after 3 weeks and grew to the size of 0.1-0.7 mm within 1 week.
X-ray Diffraction Data Measurement and Processing-Data were collected on a single crystal of wild type hTS and NTE-hTS with approximate dimensions of 0.45 ϫ 0.50 ϫ 0.50 and 0.15 ϫ 0.15 ϫ 0.15 mm, respectively. The crystals were transferred to a cryoprotectant solution containing 45% saturated ammonium sulfate, 30% concentrated ethylene glycol, and 100 mM Tris-HCl (pH 7.8), and flash-cooled in N 2 vapors at Ϫ178°C. Crystallographic diffraction experiments were carried out at the SBC insertion device beamline of the advanced photon source at Argonne National Laboratory using x-rays of 0.9793-Å wavelength. The data for unblocked hTS and NTE-hTS were collected at a crystal to detector distance of 225 and 180 mm, respectively, and processed with the HKL 2000 suit of programs (17) . At the initial stage of our analysis the coordinates of hTS were not available; therefore, a structure of ecTS (Protein Data Bank code 1(18)) with appropriate modifications was used as the search model in the molecular replacement method carried out with the CNS software (19) . The final structure of unblocked hTS replaced ecTS as the initial model for NTE-hTS. The data were refined and optimized with the CNS software (19) using simulated annealing with torsional dynamics and positional and temperature refinements. Electron density maps calculated with 2F o Ϫ F c , and F o Ϫ F c coefficients were utilized to introduce manual corrections to the model with the interactive graphics program CHAIN (20) . Ribbon diagrams and wireand-basket models were prepared with the programs MOLSCRIPT (21) and CHAIN (20) , respectively.
Fluorescence Studies-Evidence for the existence of the inactive loop conformation in solution was obtained utilizing a spectrofluorometer (Model 8100, SLM-Aminco Inc., Urbana, IL). The excitation wavelength was set at 295 nm, and the emission was scanned from 305 to 450 nm at a rate of 5 nm/s. An Ultra-Vu polystyrene cuvette (Baxter Diagnostics Inc., Deerfield, IL) was used to hold a 3-ml sample containing 4 M protein in 50 mM Tris-base (pH 7.4). The purity of the protein (recombinant wild type TS) was better than 95%. The titration was carried out 
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by addition of potassium phosphate (pH 7.4) or dUMP in increments up to 10% of the sample volume. No fluorescence signal was observed from the buffer (Tris-HCl), phosphate, or dUMP in the experiments. All measurements were done in triplicate to eliminate errors introduced by non-homogeneity of the sample and instrumental drift.
RESULTS

Determination of Steady-state Kinetic Constants for NTEhTS and hTS-
The specific activities, determined at 25°C, for NTE-hTS and hTS were 1.1 and 1.2 units/mg, respectively, whereas catalytic rates (k cat ) were 1.5 and 1.6 s Ϫ1 . These values were very similar to previously published values of 1.2 units/mg for the specific activity and 1.5 s Ϫ1 for k cat of hTS at 25°C (10, 22) .
Determination of Kinetic and Thermodynamic Constants for Nucleotide Binding to NTE-hTS-
The time courses of fluorescence quenching upon nucleotide binding were analyzed using single-exponential curve fits (23) . Kinetic and thermodynamic constants for nucleotide binding were determined as previously described (16, 23) . A linear relationship was observed between k obs and nucleotide concentration. The kinetic and thermodynamic constants for nucleotide binding to NTE-hTS are listed in Table I . The kinetic and thermodynamic constants describing nucleotide binding to NTE-hTS are nearly identical to those determined for hTS by transient-state kinetic analysis (16) .
Determination of Kinetic and Thermodynamic Constants for CH 2 H 4 folate Binding to the Binary Complex of NTE-
hTS⅐dUMP-Fluorescence quenching due to CH 2 H 4 folate binding to the binary complex of NTE-hTS⅐dUMP was analyzed using a single-exponential curve with a steady-state parameter to account for product formation as previously described (23) . Mixing NTE-hTS with substrates resulted in a fluorescence burst (k burst ) at 340 nm. The dependence of k burst on CH 2 H 4 folate concentration was hyperbolic as previously observed for hTS (13), and the kinetic and thermodynamic constants for CH 2 H 4 folate binding to NTE-hTS⅐dUMP were determined using the expression: (23) . The kinetic and thermodynamic constants determined for NTE-hTS are shown in Table II and are similar to those determined for hTS by transient-state kinetic analysis (16) .
Crystallization-The typical high salt conditions used by Schiffer et al. (2) and in the present report exclusively support the growth of hTS crystals in which the active-site loop adopts the inactive conformation. We have investigated other crystallization conditions, especially those with low ionic strength, and obtained several systems that were able to grow hTS crystals. A semi-factorial approach was employed to screen a wide variety of conditions arranged into matrices containing polyethylene glycols, different buffers, and a multitude of salts at varying concentrations (data not shown). At 38% (weight/ volume) PEG 4000, 100 mM Tris-HCl (pH 7.6), 20 mM 2-ME, and 2% saturated ammonium sulfate, thin and irregularly shaped crystals were observed after 3 weeks measuring ϳ0.1 ϫ 0.2 ϫ 0.2 mm. Despite their fair size, these crystals did not scatter x-rays at all. However, we succeeded in growing trigonal crystals, similar to those reported here and by Schiffer et al.
(2) with the PEG/ammonium sulfate biphasic system (24) . The optimum conditions were at 15-30% (weight/volume) PEG 4000, 42-50% saturated ammonium sulfate, and 100 mM TrisHCl (pH 8.5). The results were similar for hTS and NTE-hTS.
Despite the extra 42 residues at the N terminus, the crystals of hTS and NTE-hTS are isomorphous and isomorphous to those reported by Schiffer et al. (2) . The crystals belong to the space group P3 1 21 with one subunit in the asymmetric part of the unit cell. The parameters and statistics of crystallographic refinements are summarized in Table III .
Folding of hTS and NTE-hTS-The protein model reported by the Stroud group (2) was, in general, excellent; however, stretches of additional residues were fit and some side chains were rebuilt to fit to the more resolved density. The hTS data, which were refined first, having a mosaicity of 0.22 and an overall R merge of 0.033, yielded excellent electron density maps. The structural differences between hTS and NTE-hTS in unliganded form appear to be insignificant and limited to occasional shifts in the solvent structure. The root-mean-square deviations of the positions of C a between hTS and NTE-hTS, was 0.16 Å. A significantly smaller number of structured water molecules observed in the NTE-hTS structure is likely to be related to the smaller crystal used and resulting quality of the data. The discussion below refers to the wild type enzyme but is valid as well for the NTE-hTS.
The N terminus is largely disordered; good density starts at Pro-26, and this region does not change between hTS, NTEhTS, and an inhibitory ternary complex of hTS with dUMP and Tomudex (ZD1694 or raltitrexed) (4) or analogous rat TS complex (PDB entry 2tsr (3)). A least-squares superposition of the C ␣ plots of hTS and the inhibitory complex is shown in Fig. 2 . Apparently, the extra N-terminal residues of NTE-hTS occupy intermolecular space in multiple positions without affecting crystal packing. The main chain follows closely the fold of ecTS starting from Glu-30, which is equivalent to Met-1 of ecTS. As previously observed in a Lactobacillus casei TS (lcTS) structure (25) , the carboxylate moiety of the N-carbamoylated ecTS occupies the same position as the carboxylate of a glutamic acid (Glu-30 in hTS), apparently forming a structural lock that isolates the rest of the TS molecule from the presence and/or conformational state of the N terminus. Indeed, a glutamic acid at this relative position is conserved in all TSs that contain additional N-terminal sequences with one exception, which contains aspartic acid. In the region preceding the first insert, there is reasonable electron density for residues 99 -106, which was not observed previously. Region 107-128, which includes the insert, is disordered in the crystals. This is in contrast to the structures of hTS⅐dUMP⅐Tomudex and rTS⅐dUMP⅐Tomu-dex complexes, in which this region has interpretable electron density (3, 4) . The second insert, residues 146 -153, has a welldefined structure in our crystals. A short loop, Thr-103 to Arg-107 in ecTS, which is solvent-exposed, is replaced in hTS with a longer loop, Ala-144 to Gln-156, which is directed in the opposite direction toward the hTS surface (Fig. 2, top) . The insert loop is quite polar with the exception of Met-149, which forms hydrophobic contacts with Thr-96 and Asn-97, and Tyr- 
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153 interacting with Phe-137. These interactions likely anchor the loop to the rest of the molecule and induce the observed ordered conformation. Although Met-149 is not conserved, equivalent residues are usually hydrophobic and probably function in a similar manner. The presence of the loop creates a cavity in which four ordered water molecules are present. The structure of this loop is in excellent agreement with that observed in the hTS⅐dUMP⅐Tomudex and rTS⅐dUMP⅐Tomudex complexes (3, 4) , indicating that its function is not related to catalysis. The active site loop 181-197 is in the inactive conformation that was reported in previous investigations (2) . The loop forms only limited intermolecular interactions: hydrophobic contacts between the side chain of Leu-189 and Pro-305 and a hydrogen bond between Pro-188 O and Arg-274 NH1. A major intramolecular interaction stabilizing the inactive conformation is hydrogen bonding between the guanidinium group of Arg-163Ј from the other subunit and peptide carbonyls of Ala-191 and Leu-192. These interactions must stabilize the inactive conformation to the extent that in this region we do not observe any disorder in electron density maps (Fig. 2, bottom) nor high temperature factors, which would be indicative of a significant population of the active conformer. In the inactive conformation, the catalytic Cys-195 is directed toward the dimer interface and, together with Cys-180 and symmetry equivalent Cys-195Ј and Cys-180Ј from the other subunit of the dimer, forms a cluster of four thiols, with S-S distances of 5-7 Å. The thiols do not form disulfide bonds between themselves and are accessible through a short channel. Indeed, they react with exogenous thiols. During the investigation, it became apparent that the enzyme is prone to oxidation despite the presence of 20 mM 2-ME in the crystallization medium. That oxidation is occurring was suggested by the observation that some cysteine residues in the crystals were modified to form S,S-(2-hydroxyethyl)thiocysteine, presumably by reacting with 2-hydroxyethyl disulfide, the product of oxidation of mercaptoethanol (2-ME). Although disorder may contribute to the spread of electron density, leading to difficulty in assessment of cysteine derivatization, density maps were analyzed at very low contouring levels to lower the probability of misinterpretation.
Solvent Structure and Ligand Binding-The high resolution and low temperature of the data collection resulted in wellresolved solvent structure. The positions of 211 water molecules, 4 phosphate/sulfate ions, and 1 glycol molecule were identified per asymmetric part of the unit cell, or one hTS subunit. The ligand, which we tentatively identified as a glycol molecule originating from the cryosolvent, is located together with a water molecule in a large cavity (Fig. 3, top) . This cavity is not present in ecTS or lcTS and is created by the replacement of ecTS Met-34 and Trp-201 with hTS Ala-63 and His-250, respectively. Alanine in this position is unique for mammalian TSs; other TSs, with the exception of the viral enzymes, have a methionine or a large hydrophobic residue in this position. The cavity is lined mostly with hydrophobic residues, although some hydrogen-bonding functions are present. The cavity is elongated and connects to the molecular surface on one side, the other end being blocked by the side chain of Gln-36, preventing the cavity from becoming a channel (Fig. 3, bottom) . The occurrence of such cavity must destabilize the folded state, so it is likely that it has some function compensating for the reduced stability. It appears that its presence is linked to the inactive conformation; in the ternary inhibitory complex hTS⅐dUMP⅐Tomudex the cavity does not exist. It may be speculated that the cavity facilitates loop 181-197 flipping. The glycol binding energy must stabilize the inactive conformation and thus it was possible that glycol might be a noncompetitive inhibitor. However, measurements of catalytic activity of hTS in the presence and absence of up to 200 mM glycol did not show significant differences. The cryoprotectant, from which the bound glycol originated, was about 5 M and moreover synergism between phosphate and glycol binding is likely.
There are four tetrahedrally shaped peaks in the ordered solvent region with environment suitable for bound phosphate/ sulfate ions. The mother liquor of the crystal used to collect data was 40 mM in phosphate and ϳ2.0 M in sulfate. Because sulfate ions often occupy phosphate-binding sites in crystals obtained with ammonium sulfate due to the similarity of their shape and charge, it is likely that the bound ions are some mixture of the two species. Three of them are located within or close to each other and in vicinity of the active site (Fig. 4) . It is not unlikely that the bound phosphate/sulfate ions map the contacts between the enzyme molecule and the phosphate moieties of a nucleic acid. Indeed, in the structure of a complex between mRNA and a sequence-nonspecific mRNA binding protein, all protein⅐mRNA interactions are through the sugar phosphate backbone and most of them through arginine-phosphate ion pairs (26) . In the structure of a complex between the Sex-lethal protein isolated from Drosophila melanogaster and 
. R free ϭ crystallographic R-factor for test set as implemented in CNS version 1.0 (19) .
c Root-mean-square deviation. d Reference molecule.
12-nucleotide, single-stranded RNA, which is an example of mRNA sequence-specific binding, many arginine-phosphate ion pairs are observed (27) . In hTS, one distance between two phosphate/sulfate sites, 6.5 Å, is the same as phosphate-phosphate distances in single-stranded RNA helices (26) . The other distance is 10.0 Å and may correspond to a second neighbor phosphate-phosphate. Indeed, in the Sex-lethal protein⅐RNA complex, several second neighboring phosphates are separated by distances of ϳ10.4 Å (27).
Fluorescence Measurements-The observed involvement of the residues of loop 181-193 in phosphate ion binding sites suggested that phosphate concentration might affect the loop conformation. The loop has a tryptophan at position 182 and our modeling, based on the structure of the hTS⅐dUMP⅐Tomu-dex complex, showed that the position of the indole moiety differs between the active and inactive conformations by about 5 Å. It appeared likely that even with five tryptophans per subunit such change would be reflected in the enzyme fluorescence. This hypothesis turned out to be true, because there is a strong phosphate ion concentration-dependent increase in the intensity of hTS fluorescence (Fig. 5, top) . Subsequent dUMP binding effectively reverses this signal enhancement as fluorescence falls below the intensity level observed for the unliganded hTS (Fig. 5, center) . This indicates that even without phosphate ions present a significant fraction of the enzyme is in the inactive conformation and eliminates the possibility that the inactive conformation is an "artifact of the crystal field." Such effects were not observed in ecTS (Fig. 5, bottom) for which the inactive conformation has not been observed. DISCUSSION Previous studies indicated that modifications at the N terminus of hTS alter catalytic activity and RNA binding activity, presumably through effects on the enzyme conformation (8) . In the present investigation, the reaction mechanisms and crystal structures of recombinant hTS with an unmodified N terminus and hTS with an extended N terminus have been determined. Our data indicate that the presence of an additional 42 amino acids at the N terminus of hTS exerts a minimal effect on ligand binding and on the kinetically measurable steps in the reaction pathway. These results are supported by crystallographic data, which indicate no significant differences in the arrangement of atoms that were ordered in crystals. It appears that the modification of the N terminus induces only local (18)). The orientation of the second insert, Ala-144 to Gln-156, is opposite to that of the corresponding shorter loop in ecTS, and is directed toward the surface of the molecule. Bottom, electron density for the loop 181-197 contoured at 1.2s does not suggest disorder and thus the presence of active conformer in the crystal. differences that do not propagate to the rest of the molecule. The poor conservation of the amino acid sequence at the N terminus strongly suggests that the physiological function of the N-terminal extension, if such indeed exists, is strongly species-specific and thus is unlikely to be related to catalysis, in agreement with our experimental data.
FIG. 4.
Several new structural features of hTS have been deduced from the high resolution model reported here. Of interest is the possibility that they may represent sites for interactions of TS with macromolecules. Evidence that TS is involved in protein⅐protein interactions was derived from studies indicating that it is a component of a multienzyme DNA-biosynthesizing complex termed the replitase (29) . The identification of two cavities specific for mammalian TSs suggests that they are related to interaction between hTS and other macromolecules and opens a new field for studies of this amazingly complex enzyme.
A large body of evidence indicates that hTS interacts with ribonucleic acids (6, 30 -32) . At least 11 ribonucleoprotein complexes involving hTS have been identified in vivo, including complexes with TS mRNA and mRNA encoding the tumor suppressor gene product, p53 (30 -32) . No consensus sequences or structures have been identified among the RNAs interacting with hTS. The binding of hTS to TS mRNA and to p53 mRNA inhibits translation in vitro (6, 32) . That translational regulation by TS occurs in vivo is supported by recent studies of interactions between TS and p53 mRNA (33) . Binding motifs of 36 and 70 nucleotides have been identified for the interaction between TS and TS mRNA (30, 34) ; however, the site(s) of interaction on the human protein have not been identified. The crystal structures analyzed in the present investigation provide the first suggestion of the location of a region in which multiple phosphate substituents are predicted to bind whereas fluorescence studies correlate it with the inactive conformation of loop 181-197. It is possible that the inactive conformation makes hTS less vulnerable to an oxidative stress or other factors that derivatize thiols, however, it appears more probable that the inactive conformation facilitates the binding of nucleic acids, because Arg-185 of the loop binds one of the closely positioned phosphate/sulfate ions.
The existence of the inactive conformation offers a novel mechanism for inhibition of hTS. Its stabilization should be an effective manner of inhibiting hTS and providing an alternative to active site-directed inhibitors that are currently used in cancer therapy. Inhibitors stabilizing the inactive conformation and binding away from the active site may be of significant advantage, because they would be expected not to interfere with mRNA binding to hTS. Active site-directed inhibitors, such as FdUMP, inhibit the binding of hTS to TS mRNA in vitro, reducing the repression by TS of TS mRNA translation (6) . In addition, exposure of tumor cells to active site-directed inhibitors results in a significant increase in steady-state levels of TS protein (35) (36) (37) . Two mechanisms underlying the elevation in protein have been documented in different cell lines. The first emphasizes translational derepression by TS binding to TS mRNA, the second the increased stabilization of the protein upon ligand binding (6, 7) . Our structural data strongly support both mechanisms. The putative mRNA binding site involves the inactive conformation of loop 181-197 and overlaps the active site. Thus, the formation of inhibitory complexes must eliminate mRNA binding. The ternary inhibitory complex has a much more compact structure than the native TS (4). Disordered loop 107-128 is likely to be more prone to degradation than the same residues in the compact conformation observed in the inhibitory complex.
Therapeutic approaches aimed at the stabilization of the inactive conformer should not activate those mechanisms that lead to TS accumulation and may improve the outcome of cancer chemotherapy in which TS is the target. Such approaches may utilize more powerful inhibitors binding in the glycol cavity or cross-linking of the cluster of four thiols from Cys-195, Cys-180, and their equivalents from the other subunit.
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FIG. 5. Fluorescence of hTS and ecTS.
Top, enhancement effect of phosphate ion on hTS fluorescence. Middle, reversal of the effect by dUMP. All samples, except hTS, have the same concentration of P i (64 mM) and, additionally, dUMP at the concentration as shown in the inset (the order of the curves is the same as indicated in the legend, except for unliganded hTS). Bottom, no effect on ecTS.
